BlackRock, Inc. 13D and 13G filings for Agios Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-25 1:48 pm Purchase |
2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
BLACKROCK INC BLK |
4,962,237 8.900% |
193,363 (+4.05%) |
Filing |
| 2023-01-25 10:36 am Sale |
2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
BLACKROCK INC BLK |
4,768,874 8.700% |
-735,122 (-13.36%) |
Filing |
| 2022-03-09 5:18 pm Purchase |
2022-02-28 | 13G | Agios Pharmaceuticals, Inc. AGIO |
BLACKROCK INC BLK |
5,503,996 10.100% |
95,460 (+1.76%) |
Filing |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
BLACKROCK INC BLK |
5,408,536 9.950% |
-523,124 (-8.82%) |
Filing |
| 2021-08-09 3:23 pm Purchase |
2021-07-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
BLACKROCK INC BLK |
5,931,660 10.100% |
1,446,660 (+32.26%) |
Filing |
| 2021-01-28 5:55 pm Purchase |
2020-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
BLACKROCK INC BLK |
4,485,000 6.500% |
591,606 (+15.20%) |
Filing |